- Ticker
- ADIL
- Price
- 0.40
- Stock movement down
- -0.01 (-2.70%)
- Company name
- Adial Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 10.84M
- Ent value
- 7.42M
- Price/Sales
- -
- Price/Book
- 2.00
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -79.81%
- 3 year return
- -30.37%
- 5 year return
- -
- 10 year return
- -
Last updated: 2023-03-22
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
March 31, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
March 7, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
ADIL does not pay dividends or no data was received
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
February 24, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
November 14, 2022
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 2.00 |
| EV to Sales | - |
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
August 22, 2022
iO Charts is a Seeking Alpha partner
Onward Phase III Clinical Trial of Adial Pharmaceutical’s AD04, a treatment for Alcohol Abuse Disorder, was completed in early 2022. Read about the stock outlook here.
August 22, 2022
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 26.85M |
| EPS (TTM) | -0.61 |
| FCF per share (TTM) | -0.46 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -16.06M |
| Net income (TTM) | -15.70M |
| EPS (TTM) | -0.61 |
| EPS (1y forward) | -0.56 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.75M |
| Net receivables | 0.00 |
| Total current assets | 6.77M |
| Goodwill | 248.97K |
| Intangible assets | 4.62K |
| Property, plant and equipment | 0.00 |
| Total assets | 7.74M |
| Accounts payable | 278.20K |
| Short/Current long term debt | 220.25K |
| Total current liabilities | 1.33M |
| Total liabilities | 2.33M |
| Shareholder's equity | 5.41M |
| Net tangible assets | 4.70M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -11.81M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -11.81M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -290.17% |
| Return on Assets | -202.74% |
| Return on Invested Capital | -287.25% |
| Cash Return on Invested Capital | -216.11% |
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
August 17, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
August 16, 2022
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.41 |
| Daily high | 0.43 |
| Daily low | 0.40 |
| Daily Volume | 143K |
| All-time high | 8.33 |
| 1y analyst estimate | 8.50 |
| Beta | 0.59 |
| EPS (TTM) | -0.61 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 15 May 2023 |
Downside potential
Loading...
Downside potential data
| ADIL | S&P500 | |
| Current price drop from All-time high | -95.15% | -17.92% |
| Highest price drop | -97.56% | -56.47% |
| Date of highest drop | 12 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -72.32% | -11.51% |
| Avg time to new high | 106 days | 13 days |
| Max time to new high | 1054 days | 1805 days |
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
July 20, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
June 14, 2022
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
10.84M
Marketcap category
Small-cap
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Employees
16
Website
Investor relations
-
SEC filings
CEO
William B. Stilley
Country
USA
City
Charlottesville
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
May 16, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
May 16, 2022
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
February 11, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
January 24, 2022
iO Charts is a Seeking Alpha partner
COMPANY NEWS
All newsPress releases
Secured meetings with U.S. and European regulatory agencies Advancing partnership activities in both the U.S. and Europe Ended 2022 fiscal year with cash and cash equivalents of $4.0 million CHARLOTTE...
March 30, 2023
The Keswick Group is led by experienced pharmaceutical business development executive, Tony GoodmanCHARLOTTESVILLE, Va., March 21, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; A...
March 21, 2023
CHARLOTTESVILLE, Va., March 08, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing ...
March 8, 2023
Adial Pharmaceuticals Inc (NASDAQ: ADIL) shares are trading higher after an update on its regulatory strategy for AD04, the company's lead compound for Alcohol Use Disorder (AUD). The company said add...
March 7, 2023
ADial Pharmaceuticals stock soars after alcohol disorder treatment clinical trial news, Squarespace rises after estimate-beating results.
March 7, 2023
Company to pursue path toward U.S. and European approvals; Type C meeting with FDA confirmed for Q2 2023; plans in place to meet with multiple European regulatory authoritiesAdial in discussions with ...
March 6, 2023
Management to provide an update on its regulatory and partnering strategy for the United States and EuropeCHARLOTTESVILLE, Va., March 02, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ...
March 2, 2023
With the business potentially at an important milestone, we thought we'd take a closer look at Adial Pharmaceuticals...
February 28, 2023
CHARLOTTESVILLE, Va., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing t...
February 27, 2023
CHARLOTTESVILLE, Va., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing t...
February 24, 2023
Next page
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
October 21, 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
September 28, 2021
iO Charts is a Seeking Alpha partner